Optimizing HIV prevention for high-risk meth-using men who have sex with men
Official title: Optimizing HIV prevention for high-risk methamphetamine-using men who have sex with men
Funded at Graduate School of Public Health and Health Policy · NIH-11362220 · Data updated 2026-11-12
A large HIV prevention project focuses on meth-using MSM to understand why HIV risk is higher and to test telehealth coaching to help them start or stay on PrEP.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Graduate School of Public Health and Health Policy NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | April 8, 2022 |
| Project end | April 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $2,249,856 |
| NIH project number | 5UH3AI169652-05 |
| Project ID | NIH-11362220 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are men who have sex with men, use meth, and are at risk for HIV or considering PrEP.
✕Less likely to help
People not at risk for HIV or not interested in PrEP may see limited direct benefit.
What this research studies
This project follows an urgent HIV prevention need among men who have sex with men who use meth. It combines looks at social, structural, and biological factors to understand seroconversion risk and tests a telehealth motivational program to help MSM enter or re-enter the PrEP care pathway. A new prospective cohort of 5,000 MSM will be enrolled, including 3,000 meth users and 2,000 non-users, with comprehensive biospecimen and behavioral data. The study aims to map where meth use and HIV risk intersect, how to support PrEP access, and whether meth use influences rectal immune factors related to HIV risk. Results could guide targeted interventions to reduce new HIV infections in this high-risk group.
Why it matters
Potential benefit: If successful, the program could improve PrEP access and reduce HIV infections among meth-using MSM.
How similar studies have gone: Prior studies show meth use increases HIV risk among MSM, and telehealth PrEP support has shown promise in improving access in some settings.
Where this research is happening
-
Graduate School of Public Health and Health Policy
New York, United States Active
Researchers
- Principal investigator: Grov, Christian — Graduate School of Public Health and Health Policy
- Study coordinator: Grov, Christian
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Adolescent girls in Uganda: a long-term look at how money empowerment and family support affect HIV prevention, care, and mental health
A long-term study in rural Uganda will test whether an intervention that combines economic empowerment and family strengthening can help HIV-negative and HIV-affected adolescent girls move safely into young adulthood.
-
Long-term HIV prevention and mental health support for adolescent girls and young women in Uganda
A long-term program in rural Uganda tests if combining economic support and family strengthening helps teenage girls stay HIV-free and improve mental health as they grow into young adults.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.